Lower drug sales potential at Bayer underscores need for deals
2018-12-5 03:51 pm
Germany's Bayer , which acquired seed company Monsanto this year, reduced its combined sales estimate for its most promising experimental drugs, acknowledging it needs to do more to replenish the development pipeline.
Read The Rest at
Danske investors bank on Maersk clan to chart...
OPEC works on deal to cut output, still needs...
You May Also Like
Government wants credit flow at lower interest...
CDC director advises protesters get tested for...
Asia Today: Most of 51 new SKorea cases linked...
Best iTunes movie deals to start off Pride Month
Bruce Arians salivating over potential for Tom...
Cristobal turns north, sets sights on Gulf...
Berlin / Germany
Sydney / Australia
All Rights Reserved
Powered By RSS-Script Light Version